| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7.5K | $12.1K | $1.61 | 03 Sep 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15K | 03 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Director | 04 Sep 2025, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 26 Jun 2025 | 0 | $0 | 3 | Director | 03 Jul 2025, 16:30 |